Hydrazine, methyl-
RTECS #
MV5600000
CAS #
Updated
December 2018
Molecular Weight
46.09
Molecular Formula
CH6N2
Synonyms
1-Methylhydrazine
Methyl hydrazine
Methylhydrazine (ACGIH:OSHA)
Metylohydrazyna (Polish)
MMH
Monomethylhydrazine (OSHA)
RCRA waste number P068
Methyl hydrazine
Methylhydrazine (ACGIH:OSHA)
Metylohydrazyna (Polish)
MMH
Monomethylhydrazine (OSHA)
RCRA waste number P068
Mutation Data and Reference
System Test | Route/Organism/Tissue | Dose | Reference |
---|---|---|---|
DNA adduct | fibroblast/human | 116 pmol | NTIS** AD-A092-249 |
DNA inhibition | Ascites tumor/mouse | 581 µmol/L | JJATDK 1,243,1981 |
Dominant Lethal Test | intraperitoneal/rat | 1075 mg/kg/5D- intermittent | NTIS** AD-A041-973 |
mutation in microorganisms | /Salmonella typhimurium | 10 µmol/plate (+enzymatic activation step) | MUREAV 54,167,1978 |
mutation in microorganisms | /Salmonella typhimurium | 1 µL/plate (-enzymatic activation step) | NTIS** AD-A041-973 |
mutation in microorganisms | /Escherichia coli | 500 nmol/disc (-enzymatic activation step) | MUREAV 71,269,1980 |
other mutation test systems | Ascites tumor/mouse | 758 µmol/L | JJATDK 1,243,1981 |
Unscheduled DNA Synthesis | ovary/hamster | 1 µmol/L | NTIS** AD-A075-605 |
Unscheduled DNA Synthesis | lung/hamster | 1 µmol/L | NTIS** AD-A075-605 |
Unscheduled DNA Synthesis | lung/rat | 1 µmol/L | NTIS** AD-A075-605 |
Reproductive Effects Data and References
Route/Organism | Dose | Effect | Reference |
---|---|---|---|
intraperitoneal/rat | 100 mg/kg (6-15D pregnant) | Reproductive: Effects on fertility: Post- implantation mortality (e.g., dead and/or resorbed implants per total number of implants) | APTOD9 19,A21,1980 |
intraperitoneal/rat | 50 mg/kg (6-15D pregnant) | Reproductive: Specific developmental abnormalities: Eye, ear | APTOD9 19,A21,1980 |
intravenous/rat | 24 mg/kg (6-13D pregnant) | Reproductive: Effects on fertility: Post- implantation mortality (e.g., dead and/or resorbed implants per total number of implants) Reproductive: Other effects to embryo or fetus | FACOEB 10,391,1993 |
intravenous/rat | 33600 µg/kg (6-13D pregnant) | Reproductive: Effects on fertility: Female fertility index (e.g., # females pregnant per # sperm positive females; # females pregnant per # females mated) | FACOEB 10,391,1993 |
oral/rat | 5 mg/kg (6D pregnant) | Reproductive: Effects on fertility: Pre- implantation mortality (e.g., reduction in number of implants per female; total number of implants per corpora lutea) | FACOEB 10,391,1993 |
Tumorigenic Data and References
Route/Organism | Dose | Effect | Reference |
---|---|---|---|
inhalation/hamster | lowest published toxic concentration: 5 ppm/6H/1Y- intermittent | Tumorigenic: Neoplastic by RTECS criteria Olfaction: Tumors Endocrine: Adrenal cortex hyperplasia | NTIS** AD-A154-659 |
inhalation/mouse | lowest published toxic concentration: 2 ppm/6H/1Y- intermittent | Tumorigenic: Carcinogenic by RTECS criteria Liver: Tumors | NTIS** AD-A154-659 |
inhalation/rat | lowest published toxic concentration: 20 ppb/6H/1Y- intermittent | Tumorigenic: Carcinogenic by RTECS criteria Blood: Leukemia | NTIS** AD-A154-659 |
intraperitoneal/mouse | lowest published toxic dose: 72 mg/kg/8W- intermittent | Tumorigenic: Equivocal tumorigenic agent by RTECS criteria Lung, Thorax, or Respiration: Tumors | JNCIAM 42,337,1969 |
oral/hamster | lowest published toxic dose: 3000 mg/kg/47W- continuous | Tumorigenic: Carcinogenic by RTECS criteria Gastrointestinal: Colon tumors Liver: Tumors | CNREA8 33,2744,1973 |
oral/hamster | toxic dose: 5768 mg/kg/2Y- continuous | Tumorigenic: Equivocal tumorigenic agent by RTECS criteria Liver: Tumors | AJPAA4 70,102,1973 |
oral/mouse | lowest published toxic dose: 10 gm/kg/1Y- continuous | Tumorigenic: Neoplastic by RTECS criteria Lung, Thorax, or Respiration: Tumors Blood: Lymphoma including Hodgkin's disease | IJCNAW 9,109,1972 |
Acute Toxicity Data and References
Route/Organism | Dose | Effect | Reference |
---|---|---|---|
inhalation/Dog | lethal concentration (50 percent kill): 96 ppm/1H | AIHAAP 31,667,1970 | |
inhalation/guinea pig | lethal concentration (50 percent kill): 270 mg/m3/4H | Brain and Coverings: Other degenerative changes Lung, Thorax, or Respiration: Acute pulmonary edema Liver: Liver function tests impaired | STGNBT -,163,1999 |
inhalation/hamster | lethal concentration (50 percent kill): 143 ppm/4H | Behavioral: Convulsions or effect on seizure threshold | AMIHAB 12,609,1955 |
inhalation/monkey | Lowest published lethal concentration: 16 ppm/10M | TOXID9 44,303,2005 | |
inhalation/monkey | Lowest published lethal concentration: 5.5 ppm/30M | TOXID9 44,303,2005 | |
inhalation/monkey | Lowest published lethal concentration: 2.7 ppm/1H | TOXID9 44,303,2005 | |
inhalation/monkey | Lowest published lethal concentration: 0.68 ppm/4H | TOXID9 44,303,2005 | |
inhalation/monkey | Lowest published lethal concentration: 0.34 ppm/8H | TOXID9 44,303,2005 | |
inhalation/monkey | lethal concentration (50 percent kill): 82 ppm/1H | Eye: Conjunctiva irritation Gastrointestinal: Nausea or vomiting Behavioral: Convulsions or effect on seizure threshold | AIHAAP 31,667,1970 |
inhalation/mouse | lethal concentration (50 percent kill): 56 ppm/4H | Eye: Other eye effects Behavioral: Convulsions or effect on seizure threshold Lung, Thorax, or Respiration: Dyspnea | AMIHAB 12,609,1955 |
inhalation/rat | lethal concentration (50 percent kill): 34 ppm/4H | AMRL** TR-67-137,1967 | |
intraperitoneal/hamster | lethal dose (50 percent kill): 21 mg/kg | CTOXAO 4,435,1971 | |
intraperitoneal/mouse | lethal dose (50 percent kill): 15 mg/kg | Eye: Miosis (pupilliary constriction) Behavioral: Convulsions or effect on seizure threshold Skin and Appendages: Other: Hair | PSEBAA 124,172,1967 |
intraperitoneal/rat | lethal dose (50 percent kill): 21 mg/kg | CTOXAO 4,435,1971 | |
intravenous/Dog | lethal dose (50 percent kill): 12 mg/kg | Blood: Methemoglobinemia- Carboxhemoglobinemia | PSEBAA 131,226,1969 |
intravenous/mouse | lethal dose (50 percent kill): 33200 µg/kg | MEPAAX 24,71,1973 | |
intravenous/rabbit | lethal dose (50 percent kill): 12 mg/kg | Blood: Methemoglobinemia- Carboxhemoglobinemia | PSEBAA 131,226,1969 |
intravenous/rat | lethal dose (50 percent kill): 17 mg/kg | CTOXAO 4,435,1971 | |
oral/hamster | lethal dose (50 percent kill): 22 mg/kg | CTOXAO 4,435,1971 | |
oral/mouse | lethal dose (50 percent kill): 29 mg/kg | Behavioral: Somnolence (general depressed activity) Behavioral: Convulsions or effect on seizure threshold Behavioral: Excitement | NTIS** AD-A125-539 |
oral/rat | lethal dose (50 percent kill): 32 mg/kg | Behavioral: Convulsions or effect on seizure threshold | XAWPA2 CWL 2-10,1958 |
skin/guinea pig | lethal dose (50 percent kill): 48 mg/kg | Blood: Methemoglobinemia- Carboxhemoglobinemia | PSEBAA 131,226,1969 |
skin/hamster | lethal dose (50 percent kill): 239 mg/kg | CTOXAO 4,435,1971 | |
skin/rabbit | lethal dose (50 percent kill): 95 mg/kg | Blood: Methemoglobinemia- Carboxhemoglobinemia | PSEBAA 131,226,1969 |
skin/rat | lethal dose (50 percent kill): 183 mg/kg | CTOXAO 4,435,1971 | |
subcutaneous/mouse | lethal dose (50 percent kill): 25 mg/kg | BJCAAI 30,429,1974 | |
subcutaneous/rat | lethal dose (50 percent kill): 35 mg/kg | BJCAAI 30,429,1974 |
Other Multiple Dose Data and References
Route/Organism | Dose | Effect | Reference |
---|---|---|---|
inhalation/Dog | lowest published toxic concentration: 200 ppb/24H/30W- continuous | Blood: Methemoglobinemia- Carboxhemoglobinemia Nutritional and Gross Metabolic: Changes in: P Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Phosphatases | NTIS** AD734-543 |
inhalation/Dog | lowest published toxic concentration: 200 ppb/24H/26W- continuous | Blood: Changes in bone marrow not included in above Blood: Changes in erythrocyte (RBC) count Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Phosphatases | NTIS** AD-751440 |
inhalation/monkey | lowest published toxic concentration: 5 ppm/6H/26W- intermittent | Blood: Other changes | NTIS** AD-751440 |
inhalation/mouse | lowest published toxic concentration: 5 ppm/6H/26W- intermittent | Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field | NTIS** AD-751440 |
inhalation/rat | lowest published toxic concentration: 200 ppb/24H/26W- continuous | Nutritional and Gross Metabolic: Weight loss or decreased weight gain | NTIS** AD-751440 |
Reviews
Organization | Standard | Reference |
---|---|---|
American Conference of Governmental Industrial Hygienists (ACGIH) | Threshold Limit Value-time-weighted average 0.01 ppm (skin) | DTLVS* TLV/BEI,2013 |
American Conference of Governmental Industrial Hygienists (ACGIH) | Threshold Limit Value-Confirmed animal carcinogen | DTLVS* TLV/BEI,2013 |
TOXICOLOGY REVIEW | MUREAV 39,111,1977 | |
TOXICOLOGY REVIEW | ARVPAX 5,447,1965 | |
TOXICOLOGY REVIEW | JEMME* 28,175,2005 | |
TOXICOLOGY REVIEW | ENTOX* -,171,2005 | |
TOXICOLOGY REVIEW | MUREAV 584,1,2005 | |
TOXICOLOGY REVIEW | RTOPDW 54,247,2009 |
Standards and Regulations
Organization | Standard | Reference |
---|---|---|
Mine Safety and Health Administration (MSHA) STANDARD | air-ceiling concentration 0.2 ppm (0.35 mg/m3) (skin) | DTLVS* 3,174,1971 |
Occupational Exposure Limit IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN check ACGIH TLV; | ||
Occupational Exposure Limit IN SINGAPORE, VIETNAM check ACGIH TLV | ||
Occupational Exposure Limit-AUSTRALIA | time-weighted average 0.01 ppm (0.019 mg/m3), Carcinogen, JUL2008 | |
Occupational Exposure Limit-BELGIUM | time-weighted average 0.01 ppm (0.019 mg/m3), Skin, MAR2002 | |
Occupational Exposure Limit-DENMARK | time-weighted average 0.01 ppm (0.02 mg/m3), skin, MAY2011 | |
Occupational Exposure Limit-FINLAND | time-weighted average 0.01 ppm (0.02 mg/m3), skin, NOV2011 | |
Occupational Exposure Limit-FRANCE | VME 0.2 ppm (0.35 mg/m3), FEB2006 | |
Occupational Exposure Limit-ICELAND | time-weighted average 0.04 ppm (0.08 mg/m3), skin, NOV2011 | |
Occupational Exposure Limit-KOREA | ceiling concentration 0.2 ppm (0.35 mg/m3), skin, 2006 | |
Occupational Exposure Limit-MEXICO | time-weighted average 0.01 ppm (0.019 mg/m3), 2004 | |
Occupational Exposure Limit-NEW ZEALAND | ceiling concentration 0.2 ppm (0.38 mg/m3), skin, JAN2002 | |
Occupational Exposure Limit-NORWAY | time-weighted average 0.08 mg/m3, JAN1999 | |
Occupational Exposure Limit-PERU | time-weighted average 0,01 ppm (0,019 mg/m3), JUL2005 | |
Occupational Exposure Limit-POLAND | MAC(time-weighted average) 0.02 mg/m3, MAC(short term exposure limit) 0.1 mg/m3, JAN1999 | |
Occupational Exposure Limit-SWEDEN | Group B Carcinogen, JUN2005 | |
Occupational Exposure Limit-SWITZERLAND | MAK-week 0.2 ppm (0.35 mg/m3), skin, JAN2011 | |
Occupational Exposure Limit-THAILAND | time-weighted average 0.2 ppm (0.35 mg/m3), JAN1993 | |
Occupational Exposure Limit-THE NETHERLANDS | MAC-C 0.35 mg/m3, Skin, 2003 | |
Occupational Safety and Health Administration (OSHA) Permissible Exposure Limit (Construction) | ceiling concentration 0.2 ppm (0.35 mg/m3) (skin) | CFRGBR 29,1926.55,1994 |
Occupational Safety and Health Administration (OSHA) Permissible Exposure Limit (Federal Contractors) | ceiling concentration 0.2 ppm (0.35 mg/m3) (skin) | CFRGBR 41,50-204.50,1994 |
Occupational Safety and Health Administration (OSHA) Permissible Exposure Limit (General Industry) | ceiling concentration 0.2 ppm (0.35 mg/m3) (skin) | CFRGBR 29,1910.1000,1994 |
Occupational Safety and Health Administration (OSHA) Permissible Exposure Limit (Shipyards) | ceiling concentration 0.2 ppm (0.35 mg/m3) (skin) | CFRGBR 29,1915.1000,1993 |
NIOSH Documentation and Surveillance
Organization | Standard | Reference |
---|---|---|
National Institute for Occupational Safety and Health (NIOSH) Recommended Exposure Level TO METHYLHYDRAZINE-air | Carcinogen ceiling concentration 0.04 ppm/120M | NIOSH* DHHS #92-100,1992 |
National Occupational Exposure Survey 1983 | Hazard Code X4272; Number of Industries 1; Total Number of Facilities 14; Number of Occupations 2; Total Number of Employees Exposed 1473; Total Number of Female Employees Exposed 230 |
Status in Federal Agencies
Page last reviewed: November 16, 2018
Content
source: National Institute for Occupational Safety and Health